The PROHEMA brand, founded in 2011 (United States), from 2 sister brands and 2214 competing brands. PROHEMA is owned by Fate Therapeutics, listed on the stock exchange of New York PROHEMA is part of the Biotechnology activity sector.

PROHEMA is a brand of Fate Therapeutics (FATE) Share price

International deposit : 2011 Business sector Biotechnology

Share price and profitability of the share Fate Therapeutics (PROHEMA)

Buy Fate Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 5.04

Portfolio valuation
Fate Therapeutics (PROHEMA) over 5 years* USD 1.53

Stock market history Fate Therapeutics (PROHEMA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Fate Therapeutics

See more brands of Fate Therapeutics

Rival brands
PROHEMA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS